glp 1 dos and don ts GLP-1 Medications Infographic GLP-1 Meds: What They Really

These GLP-1 receptor agonists can be categorized as either short-acting compounds, which provide short-lived receptor activation (such as exenatide and lixisenatide) or as long-acting compounds (for example albiglutide, dulaglutide, exenatide long-acting release, and liraglutide), which activate the GLP-1 receptor continuously at their recommended dose

By helping patients lose weight, Wegovy can also lower the risk of cardiovascular events like heart attack or heart disease

Our body naturally produces a hormone called GLP-1 in our gut

These are called bellwether trials. The courts goal is that these few trials can result in a settlement program without having to hold trials for each of the thousands of cases that are filed

The new biology and pharmacology of glucagon

Aphaia Pharma Headquarters: Switzerland Technology: oral glucose formulation Lead candidate: APH-012 As disruptions in the guts natural responses to food intake are linked to metabolic diseases, such as obesity, Swiss biotech company Aphaia Pharma has come up with a way to restore these said natural responses, different from conventional obesity therapies like GLP-1 agonists